Impact of hepatitis B vaccination in the colombian Amazon 18 years after its implementation

Authors

  • Alexandra Porras R. National University of Colombia
  • Fernando De la Hoz R. University of London

DOI:

https://doi.org/10.17533/udea.rfnsp.26566

Abstract

La hepatitis B es un problema endémico de salud pública en muchos países alrededor del mundo. Se estima que 350 millones de personas son portadoras del virus de hepatitis B (VHB). Una vacuna altamente efectiva ha estado disponible desde principios de los años ochenta y muchos países la están utilizando para controlar la infección. Sin embargo, todavía hay muchas áreas donde la vacuna no está en uso.

|Abstract
= 303 veces | PDF (ESPAÑOL (ESPAÑA))
= 123 veces|

Downloads

Download data is not yet available.

Author Biographies

Alexandra Porras R., National University of Colombia

National University of Colombia. School of Medicine. PhD in Public Health. Bogotá, Colombia.

Fernando De la Hoz R., University of London

Doctor in epidemiology of infectious diseases. University of London. United Kingdom.

References

(1). Mc Mahon J. Natural History of Chronic Hepatitis B - Clinical Implications. Medscape J Med. 2008;10(4):91.

(2). Dehesa Violante M, Nunez Natera R. Epidemiology of hepatitis B and C. Archives of Medical Research 2007;38:606-11. DOI: https://doi.org/10.1016/j.arcmed.2007.03.001

(3). Silveira Thêmis R, Fonseca José Carlos da, Rivera Luis, Fay Oscar H, Tapia Roberto, Santos José I, et al. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Pública (serial on the Internet). 1999 Dec (cited 2011 Oct 12);6(6):378-383. DOI: https://doi.org/10.1590/S1020-49891999001100002

(4). Ruff T, Gertig D, Otto B, et al. Lombok Hepatitis B model immunization project: Toward universal infant hepatitis B immunization in Indonesia. Journal of Infectious Diseases. 1995;171:290-6. DOI: https://doi.org/10.1093/infdis/171.2.290

(5). Hsu HM, Chen DS, Chuang CH, Lu JC, Jwo DM, Lee CC, Lu HC, Cheng SH, Wang YF, Wang CY, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA. 1988;260(15):2231-2235. DOI: https://doi.org/10.1001/jama.260.15.2231

(6). Martínez M, De la Hoz F, Jaramillo LS, et al. Seroepidemiología de la infección por el virus de la hepatitis B en niños de la Amazonia Colombiana. Biomédica 1991;11:20-24. DOI: https://doi.org/10.7705/biomedica.v11i1-4.2006

(7). De la Hoz F, Perez L, De Neira M and Hall A. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine. Factors influencing hepatitis B infection and effectiveness. International Journal of Infectious Diseases 2008;12(2):183-189. DOI: https://doi.org/10.1016/j.ijid.2007.06.010

(8). De la Hoz F, Perez L, Wheeler J.G, De Neira M, and Hall AJ. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage? Tropical Medicine and International Health 2005;10(4):322-329. DOI: https://doi.org/10.1111/j.1365-3156.2005.01399.x

(9). Pineda R. Holocausto en el Amazonas. Bogotá: Editorial Espasa Fórum, Editorial Planeta Colombiana; 2000.

Published

2016-04-27

How to Cite

1.
Porras R. A, De la Hoz R. F. Impact of hepatitis B vaccination in the colombian Amazon 18 years after its implementation. Rev. Fac. Nac. Salud Pública [Internet]. 2016 Apr. 27 [cited 2025 Dec. 6];30(4.1):32-5. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/26566

Issue

Section

Research